Braak stage | Age (years) | Gender (%) | APOE genotype (%) | Postmortem delay (h) | ||||
---|---|---|---|---|---|---|---|---|
Male | Female | ε2ε3 | ε3ε3 | ε3ε4 | ε4ε4 | |||
Unfixed frozen sampes | ||||||||
Braak 0 (n = 8) | 49.50 ± 5.95 | 62.50 | 37.50 | 0.00 | 66.67 | 0.00 | 33.33 | 7.19 ± 3.29 |
Braak II (n = 26) | 77.50 ± 8.81 | 53.85 | 46.15 | 9.09 | 77.27 | 9.09 | 4.55 | 8.33 ± 5.05 |
Braak III–IV (n = 15) | 79.42 ± 12.37 | 46.66 | 53.33 | 7.69 | 61.54 | 30.77 | 0.00 | 5.42 ± 4.80 |
Braak V–VI (n = 44) | 77.98 ± 12.48 | 43.18 | 56.82 | 5.56 | 69.44 | 22.22 | 2.78 | 8.99 ± 4.55 |
Fixed samples | ||||||||
Braak 0 (n = 1) | 58 | 100.00 | 0.00 | – | – | – | –– | 5.00 |
Braak II (n = 8) | 80.86 ± 6.77 | 28.57 | 71.43 | – | – | – | – | 10.67 ± 5.46 |
Braak V–VI (n = 14) | 72.93 ± 14.06 | 64.29 | 35.71 | 14.29 | 28.57 | 57.14 | 0.00 | 7.65 ± 3.14 |